The authors of an article published in the April 2017 issue of the Journal of Clinical Psychopharmacology requested clarification of the “Author Disclosure Information” on page 167.
This information should read as follows:
“Author Disclosure Information
All coauthors are employees of Janssen Research & Development, LLC, a company that conducts research on schizophrenia and manufactures and sells antipsychotics. The authors declare no other conflicts of interest.”
Ramcharran D, Qiu H, Schuemie MJ, et al. Atypical antipsychotics and the risk of falls and fractures among older adults: An emulation analysis and an evaluation of additional confounding control strategies. J Clin Psychopharmacol